Assessing the Potency of β-Lactamase Inhibitors with Diverse Inactivation Mechanisms against the PenA1 Carbapenemase from Burkholderia multivorans
出版年份 2021 全文链接
标题
Assessing the Potency of β-Lactamase Inhibitors with Diverse Inactivation Mechanisms against the PenA1 Carbapenemase from Burkholderia multivorans
作者
关键词
-
出版物
ACS Infectious Diseases
Volume 7, Issue 4, Pages 826-837
出版商
American Chemical Society (ACS)
发表日期
2021-03-16
DOI
10.1021/acsinfecdis.0c00682
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Structural basis and binding kinetics of vaborbactam in class A β-lactamase inhibition
- (2020) Orville A. Pemberton et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Beyond piperacillin-tazobactam: cefepime and AAI101 as a potent β-lactam-β-lactamase inhibitor combination
- (2019) Krisztina M. Papp-Wallace et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Structural insights into the inhibition of the extended-spectrum β-lactamase PER-2 by Avibactam
- (2019) Melina Ruggiero et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Nacubactam Enhances Meropenem Activity against Carbapenem-Resistant Klebsiella pneumoniae Producing KPC
- (2019) Melissa D. Barnes et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- “Switching Partners”: Piperacillin-Avibactam Is a Highly Potent Combination against Multidrug-Resistant Burkholderia cepacia Complex and Burkholderia gladioli Cystic Fibrosis Isolates
- (2019) Elise T. Zeiser et al. JOURNAL OF CLINICAL MICROBIOLOGY
- The latest advances in β-lactam/β-lactamase inhibitor combinations for the treatment of Gram-negative bacterial infections
- (2019) Krisztina M. Papp-Wallace EXPERT OPINION ON PHARMACOTHERAPY
- Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix
- (2019) Dorothee Liebschner et al. Acta Crystallographica Section D-Structural Biology
- Biochemical Activity of Vaborbactam
- (2019) Ruslan Tsivkovski et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Sequence heterogeneity of the PenA carbapenemase in clinical isolates of Burkholderia multivorans
- (2018) Scott A. Becka et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Overcoming an Extremely Drug Resistant (XDR) Pathogen: Avibactam Restores Susceptibility to Ceftazidime for Burkholderia cepacia Complex Isolates from Cystic Fibrosis Patients
- (2017) Krisztina M. Papp-Wallace et al. ACS Infectious Diseases
- Exploring the role of the Ω-loop in the evolution of ceftazidime resistance in the PenA β-lactamase from Burkholderia multivorans , an important Cystic Fibrosis pathogen
- (2016) Krisztina M. Papp-Wallace et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Interaction of Avibactam with Class B Metallo-β-Lactamases
- (2016) Martine I. Abboud et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Removal of the Side Chain at the Active-Site Serine by a Glycine Substitution Increases the Stability of a Wide Range of Serine β-Lactamases by Relieving Steric Strain
- (2016) Vlatko Stojanoski et al. BIOCHEMISTRY
- Two Distinctive Binding Modes of Endonuclease Inhibitors to the N-Terminal Region of Influenza Virus Polymerase Acidic Subunit
- (2016) Satoshi Fudo et al. BIOCHEMISTRY
- Investigations on recyclisation and hydrolysis in avibactam mediated serine β-lactamase inhibition
- (2016) Hwanho Choi et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- Variants of β-Lactamase KPC-2 That Are Resistant to Inhibition by Avibactam
- (2015) Krisztina M. Papp-Wallace et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB
- (2015) James A. Maier et al. Journal of Chemical Theory and Computation
- Kinetics of Avibactam Inhibition against Class A, C, and D β-Lactamases
- (2013) David E. Ehmann et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Insights into β-Lactamases fromBurkholderiaSpecies, Two Phylogenetically Related yet Distinct Resistance Determinants
- (2013) Krisztina M. Papp-Wallace et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Routine Microsecond Molecular Dynamics Simulations with AMBER on GPUs. 2. Explicit Solvent Particle Mesh Ewald
- (2013) Romelia Salomon-Ferrer et al. Journal of Chemical Theory and Computation
- Understanding the Molecular Determinants of Substrate and Inhibitor Specificities in the Carbapenemase KPC-2: Exploring the Roles of Arg220 and Glu276
- (2012) Krisztina M. Papp-Wallace et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Placevent: An algorithm for prediction of explicit solvent atom distribution-Application to HIV-1 protease and F-ATP synthase
- (2012) Daniel J. Sindhikara et al. JOURNAL OF COMPUTATIONAL CHEMISTRY
- Design and Exploration of Novel Boronic Acid Inhibitors Reveals Important Interactions with a Clavulanic Acid-Resistant Sulfhydryl-Variable (SHV) β-Lactamase
- (2012) Marisa L. Winkler et al. JOURNAL OF MEDICINAL CHEMISTRY
- Avibactam is a covalent, reversible, non- -lactam -lactamase inhibitor
- (2012) D. E. Ehmann et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- XDS
- (2010) Wolfgang Kabsch ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Features and development ofCoot
- (2010) P. Emsley et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Three Decades of -Lactamase Inhibitors
- (2010) S. M. Drawz et al. CLINICAL MICROBIOLOGY REVIEWS
- Elucidating the role of Trp105 in the KPC-2 β-lactamase
- (2010) Krisztina M. Papp-Wallace et al. PROTEIN SCIENCE
- Inhibitor Resistance in the KPC-2 -Lactamase, a Preeminent Property of This Class A -Lactamase
- (2009) K. M. Papp-Wallace et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- IRT and CMT β-lactamases and inhibitor resistance
- (2008) R. Cantón et al. CLINICAL MICROBIOLOGY AND INFECTION
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started